1.Potlukova, E., J. Jiskra, et al. (2008) . "Autoantibodies against complement C1q correlate with the thyroid function in patients with autoimmune thyroid disease." Clin Exp Immunol 153(1): 96-101. 2.Potlukova, E. and P. Kralikova (2008) Autoantibodies against C1q (anti-C1q) have been found in a number of autoimmune and infectious diseases. Their prevalence in the general population ranges from 2 to 8 % and seems to increase with age. They have been best described in patients with systemic lupus erythematosus, where they are a reliable marker of proliferative lupus nephritis. We have previously shown that anti-C1q antibodies are also linked to autoimmune thyroid disorders (AITD).
The aim of this study: To assess the occurrence of anti-C1q antibodies in pregnant women with AITD.
Printed by
The activation of the complement system: Anti-C1q prevalence is higher in the first trimester of pregnancy as compared to non-pregnant women.
Pregnant women positively screened for AITD are more frequently positive for anti-C1q than women without thyroid disorders.
Serum levels of anti-C1q correlate with TSH in pregnant women screened positive for AITD and decrease after delivery.
Anti-C1q antibodies were higher in pregnant women than in the non-pregnant controls (12.5 vs. 7.6 mU/l, p=0.0006. Furthermore, anti-C1q prevalence were higher in pregnant women who were positive for TPOAb than in the pregnant women without thyroid disorders (12.7 vs. 6.5 mU/l; p<0.0001) (Fig.1) . Table 1 . Levels of anti-C1q and thyroid parametres in pregnant women positively screened for AITD and their follow-up after delivery.
The values are presented as the median. The normal values for pregnancy: TSH 0.06 -3.67 mIU/l, fT4 9.8 -23.1 pmol/l, TPOAb < 143 kU/l, anti-C1q < 15 mU/l. The normal values in non-pregnant women: TSH 0.37 -5.00 mIU/l, fT4 9.8 -23.1 pmol/l, TPOAb < 50 kU/l, antiC1q < 15 mU/l. 
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Similarly, the prevalence of anti-C1q positivity was higher in the TPOAbpositive pregnant women (37.2% vs. 17.5 %, p=0.006).
Among pregnant women screened positive for AITD, the anti-C1q positive ones had higher TSH levels than the anti-C1q negative ones (Fig. 2) . TSH correlated positively with anti-C1q levels in all pregnant women screened positive for AITD (r=0.20, p=0.043), as well as in the TPOAb-positive subgroup (r=0.237, p = 0.027) Differences in FT4 were not significant.
Serum levels of anti-C1q decreased significantly after delivery (12.6 vs. 9.4 U/l, p=0.026) (Fig. 3 , Tab. 1) and did not correlate with thyroid parameters at this time point.
